Latest Myriad Genetics Inc. Stories
Petitions aim to nullify cancer gene patents owned, co-owned, or licensed by Myriad Genetics, Inc. WASHINGTON, Aug.
Plaintiffs, including the American Civil Liberties Union, Association for Molecular Pathology, and American Society for Clinical Pathology, win long-fought case against Myriad Genetics, Association
A Salt Lake City, Utah-based genetics firm has lost a battle in court to keep a patent on naturally-occurring human genes.
SALT LAKE CITY, Sept. 14 /PRNewswire-FirstCall/ -- Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio.
Myriad Genetics, Inc. (NASDAQ: MYGN) today reported its first profitable quarter from operations.
- A poem in which the author retracts something said in an earlier poem.